new cancer drugs approved by Health Canada

October 2005

You may hear about new cancer drugs approved by Health Canada.

Zevalin (ibritumomab) and Bexxar (tositumomab) are for relapsed or refractory non-Hodgkin's lymphoma.

They are in a new class of drugs called radiolabelled monoclonal antibodies.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

a lot for all of us to learn from Hurricane Katrina in the U.S.
Diabetes Actos (pioglitazone) reduces the risk of heart attack and stroke in some patients with type 2 diabetes
Health Canada is stopping the sale of thioridazine
Mirapex for fibromyalgia
Interactions potentially fatal interaction between colchicine and some macrolides
Women's Health whether paroxetine (Paxil) increases the risk of birth defects
Ophthalmology Macugen is the latest treatment now approved in Canada to treat macular degeneration
Dermatology what works for diaper rash
Cardiology whether heart attack patients should get a statin IMMEDIATELY
Cardiology Stopping aspirin even short-term may increase the risk of heart attack and stroke
Cardiology Viagra does NOT seem to increase the risk of heart attack in most men
Dyslipidemia Omacor will be the first PRESCRIPTION omega-3 fatty acid product
doxycycline for OSTEOarthritis
Hematology & Oncology new cancer drugs approved by Health Canada
Home-screening tests for colon cancer are getting easier to use